Teleflex

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Teleflex and other ETFs, options, and stocks.

About TFX

Teleflex, Inc. engages in the provision of medical technology products. It operates through the following business segments: Americas, EMEA (Europe, the Middle East and Africa), Asia Pacific. 

CEO
Jason Weidman
CEOJason Weidman
Employees
15,500
Employees15,500
Headquarters
Wayne, Pennsylvania
HeadquartersWayne, Pennsylvania
Founded
1943
Founded1943
Employees
15,500
Employees15,500

TFX Key Statistics

Market cap
5.62B
Market cap5.62B
Price-Earnings ratio
-5.56
Price-Earnings ratio-5.56
Dividend yield
1.07%
Dividend yield1.07%
Average volume
447.61K
Average volume447.61K
High today
$127.60
High today$127.60
Low today
$124.89
Low today$124.89
Open price
$126.39
Open price$126.39
Volume
345.71K
Volume345.71K
52 Week high
$139.67
52 Week high$139.67
52 Week low
$100.18
52 Week low$100.18

Stock Snapshot

Teleflex(TFX) stock is priced at $126.76, giving the company a market capitalization of 5.62B. It carries a P/E multiple of -5.56 and pays a dividend yield of 1.07%.

On 2026-07-01, Teleflex(TFX) stock moved within a range of $124.89 to $127.60. With shares now at $126.76, the stock is trading +1.5% above its intraday low and -0.7% below the session's peak.

Trading activity shows a volume of 345.71K, compared to an average daily volume of 447.61K.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $139.67 and a low of $100.18.

Over the past 52 weeks, Teleflex(TFX) stock has traded between a high of $139.67 and a low of $100.18.

TFX News

Simply Wall St 2d
Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex Investors?

Teleflex Incorporated recently advanced its Freesolve Resorbable Magnesium Scaffold program by beginning enrollment in the global BIOMAG-III pivotal trial, comp...

Should Teleflex’s Bioresorbable Scaffold Trial Progress Require Action From Teleflex Investors?
Simply Wall St 3d
Teleflex Could Be 43% Undervalued Following BIOMAG III Study Enrollment

Teleflex (TFX) has caught investor attention after starting patient enrollment in the global BIOMAG-III Study for its Freesolve Resorbable Magnesium Scaffold, a...

Teleflex Could Be 43% Undervalued Following BIOMAG III Study Enrollment
Nasdaq 7d
Do Options Traders Know Something About Teleflex Stock We Don't?

Investors in Teleflex Incorporated TFX need to pay close attention to the stock based on moves in the options market lately. That is because the July 17, 2026 $...

Do Options Traders Know Something About Teleflex Stock We Don't?

Analyst ratings

71%

of 14 ratings
Buy
28.6%
Hold
71.4%
Sell
0%

People also own

Based on the portfolios of people who own TFX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.